Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs Biotech Investing
Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using its DehydraTECH technology in Delivering Antiviral Drugs Biotech Investing
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury Biotech Investing
Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Biotech Investing
European Commission Grants Marketing Authorization for Jyseleca® ? for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis Biotech Investing
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug Application for Phase II/III COVID-19 Trial Biotech Investing
Opdivo Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial Biotech Investing
Lexaria Receives Orders for 4.4 Million Servings of DehydraTECH-Enabled CBD Powders Biotech Investing
